ProShare Advisors LLC Purchases 3,036,196 Shares of Kenvue Inc. $KVUE

ProShare Advisors LLC boosted its position in Kenvue Inc. (NYSE:KVUE) by 39.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,803,027 shares of the company’s stock after purchasing an additional 3,036,196 shares during the period. ProShare Advisors LLC’s holdings in Kenvue were worth $186,352,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the company. Physician Wealth Advisors Inc. raised its stake in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after acquiring an additional 618 shares in the last quarter. Versor Investments LP raised its stake in shares of Kenvue by 2.8% during the third quarter. Versor Investments LP now owns 26,016 shares of the company’s stock valued at $422,000 after acquiring an additional 716 shares in the last quarter. Philip James Wealth Mangement LLC raised its stake in shares of Kenvue by 5.5% during the fourth quarter. Philip James Wealth Mangement LLC now owns 13,888 shares of the company’s stock valued at $240,000 after acquiring an additional 726 shares in the last quarter. Phoenix Financial Ltd. raised its stake in shares of Kenvue by 5.4% during the fourth quarter. Phoenix Financial Ltd. now owns 15,195 shares of the company’s stock valued at $262,000 after acquiring an additional 783 shares in the last quarter. Finally, Titleist Asset Management LLC raised its stake in shares of Kenvue by 1.6% during the third quarter. Titleist Asset Management LLC now owns 50,957 shares of the company’s stock valued at $827,000 after acquiring an additional 796 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the subject of several research analyst reports. Barclays decreased their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. UBS Group decreased their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Citigroup decreased their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Argus raised shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Finally, Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $19.33.

Kenvue Stock Performance

Shares of KVUE stock opened at $17.19 on Tuesday. The firm has a market cap of $33.00 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 1.30 and a beta of 0.55. The company’s 50 day moving average is $17.46 and its 200 day moving average is $17.35. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $24.35.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. Kenvue’s revenue was up 4.5% compared to the same quarter last year. During the same period last year, the company posted $0.24 earnings per share. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th will be issued a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.59% of the stock is currently owned by insiders.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.